Skip to content

Clinical trials

Phase 2/3 Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 2/3 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20053
20061
20071
20102
20111
20131
20152
20161
20171
20181
20191
20201
20211
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Unknown status4
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Post Graduate Institute of Medical Education and Research, Chandigarh4
University of Padova3
Tanta University2
University of California, San Francisco2
AbbVie1
All India Institute of Medical Sciences1
Bambino Gesù Hospital and Research Institute1
Galectin Therapeutics Inc.1
Hadassah Medical Organization1
Hospital Clinic of Barcelona1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis26
Ascites6
Liver Cirrhosis6
Hypertension, Portal4
Hepatorenal Syndrome3
Acute Kidney Injury2
Carcinoma, Hepatocellular2
Hepatic Encephalopathy2
Non-alcoholic Fatty Liver Disease2
Cross Infection1

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.